Pfizer, Merck trim prices in China for Paxlovid, molnupiravir – reports
SHANGHAI (Reuters) – Pfizer and Merck have slightly lowered the prices of their respective Paxlovid and molnupiravir COVID-19 treatments in China, local media reported on Tuesday citing pricing information published…